Regulatory T cells are present in Kaposi's sarcoma and increasingly frequent in advanced disease

D. Camarillo,K. Leslie,P. Unemori,A. Yashi,K. McCune-Smith,T. Maurer

DOI: https://doi.org/10.1186/1750-9378-4-S2-P12

2009-06-17

Infectious Agents and Cancer

Abstract:

What problem does this paper attempt to address?

Treatment of visceral artery aneurysms and pseudoaneurysms with the use of cerebral flow diverting stents: initial experience

Paolo Rabuffi,Antonio Bruni,Enzo Gabriele Maria Antonuccio,Cesare Ambrogi,Simone Vagnarelli

DOI: https://doi.org/10.1186/s42155-020-00137-y

2020-09-13

Abstract:Background: Flow-diverter stents (FDS) are designed to maintain laminar flow in the parent artery and sidebranches and to promote thrombosis of the aneurysm. Although these devices were developed for use in intracranial circulation, FDS could be employed to treat aneurysms regardless of their location, when anatomic factors may limit the efficacy of classic endovascular techniques. The objective of this study is to describe the initial experience of a single center in the treatment of visceral artery aneurysms and pseudoaneurysms (VAA-VAP) with cerebral FDS, analyzing safety, efficacy and 1-year outcome. Between 2016 and 2018 six patients (4 women, mean age 57.6) underwent treatment with FDS of 4 VAA and 2 VAP located in renal (4), hepatic (1) and splenic arteries (1). Mean aneurysm diameter was 14.3 mm (range 8-22). All the aneurysms had sidebranches arising from the neck or had an unfavorable dome-to-neck ratio. Technical success, safety, efficacy and 1-year outcome were analyzed. Follow-ups (FU) with Color-Doppler US and CTA ranged from 12 to 36 (mean 20) months. Results: Technical success was achieved in all cases. There were no aneurysm rupture nor reperfusion after exclusion. Five out of six (83.3%) FDS were patent at each FU; all the aneurysms showed shrinkage with a mean dimensional reduction rate of 55.8%. Sac thrombosis was observed in 4 aneurysms at 1 (n = 3) and at 12-month FUs. There was one sidebranch occlusion with evidence of a small area of kidney hypoperfusion at the 12-month FU, which was asymptomatic. In one patient, a reintervention was needed because CTA showed a severe in-stent stenosis, which was symptomatic. Mean hospitalization was 4.1 days. Conclusions: Treatment of morphologically complex VAA and VAP with cerebral FDS proved to be safe and efficient. Stronger evidence from larger populations are required.
Flow Diverter in Unruptured Intracranial Vertebral Artery Dissecting Aneurysm

Han San Oh,Jin Woo Bae,Chang-eui Hong,Kang Min Kim,Dong Hyun Yoo,Hyun-Seung Kang,Young Dae Cho

DOI: https://doi.org/10.3389/fneur.2022.912863

IF: 3.4

2022-06-21

Frontiers in Neurology

Abstract:Objective: Intracranial vertebral artery dissecting aneurysm (VADA) may present as aneurysmal dilation alone, dilation with coexisting stenosis, or, in some cases, as a recurrent aneurysm after previous reconstructive treatment. To date, the clinical utility of flow diverters in VADA has not been examined according to these various circumstances. This study aims to report the safety and efficacy of flow diverters in the treatment of various manifestations of intracranial VADA. Methods: A total of 26 patients and 27 VADAs treated with flow diverting stents from November 2014 to September 2021 were included. Medical records and radiologic data were analyzed to assess the safety and efficacy of flow diverting stents. Results: The results showed that 12 cases (44.4%) presented with aneurysmal dilation only, 7 (26.0%) with aneurysmal dilation and one or more associated stenotic lesions, and 8 (29.6%) as recurrence after previous treatment, including stent-assisted coil embolization ( n = 5), single stent only ( n = 1), and coil embolization without stent ( n = 2). Among 27 lesions, 25 were treated with single flow diverters; additional flow diverting stents were required in 2 cases because of incomplete coverage of the aneurysm neck. There was one instance of incomplete expansion of the flow diverter. All cases showed contrast stagnation in the aneurysmal sac immediately after deployment of the flow diverting stent, and during a mean follow-up period of 18.6 months (range 6 to 60), the overall complete occlusion rate was 55.6%, with complete occlusion of 83.3% of aneurysmal dilation only lesions, 42.9% of aneurysms with stenosis, and 25% of the recurrent aneurysm. Only two patients (7.7%) had delayed ischemic complications. Conclusion: Flow diverters have proven safe and effective in unruptured VADA. However, the complete occlusion rate with the flow diverter is relatively lower in VADA with stenosis or with previous stent placement than in dilation-only lesions. Further study with a larger cohort would be needed to confirm these results.

neurosciences,clinical neurology
Endovascular treatment of distal anterior cerebral artery aneurysms using flow modulation devices: mid- and long-term results from a two-center study

Ali Khanafer,Hans Henkes,Jose Cohen,Pablo Albiña-Palmarola,John Moshe Gomori,Michael Forsting,Philipp von Gottberg

DOI: https://doi.org/10.3389/fneur.2024.1368612

IF: 3.4

2024-03-12

Frontiers in Neurology

Abstract:Purpose: Flow-diverter (FD) stents have become an established treatment for intracranial aneurysms in recent years, but their use for aneurysms in distal cerebral vessels with small carrier vessel diameters remains controversial. This study describes the method and mid- and long-term outcomes of FD treatment of distal anterior cerebral artery aneurysms (DACAAs) at two neurointerventional centers, to elucidate this topic and provide more in-depth data. Methods: Data for all patients at two neurointerventional centers who were treated with FDs for DACAAs in the pericallosal and supracallosal segment of the anterior cerebral artery were retrospectively analyzed. Data on periprocedural complications, and short-, mid- and long-term follow-up findings were recorded. Results: Forty-one patients were eligible for inclusion in the study. Three FD models were used, one of which had an anti-thrombotic coating. Two periprocedural complications (5%) occurred but did not cause a change in the mRS. In the long-term follow-up, at 29 months and beyond, 83% of assessable patients showed complete occlusion of the aneurysms without new neurological deficits. Conclusion: FDs are a safe and effective treatment approach for DACAAs. This study indicated a low risk of complications, and high closure rates in short-, mid- and long-term follow-up.

neurosciences,clinical neurology
Flow diverters in the treatment of unruptured vertebral artery dissecting aneurysm: A single-center experience.

Xiaoyang Lu,Yuansheng Zhang,Hu Zhou,Lipeng Jian,Shi Yin,Tao Li,Wei Huang

DOI: https://doi.org/10.3389/fneur.2023.1050619

IF: 3.4

2023-01-01

Frontiers in Neurology

Abstract:FD is an effective and safe tool for treating unruptured VADA. Long-term prospective studies with a large sample are still needed to confirm these findings in the future.
Flow-Diverting Devices in the Treatment of Vertebral Artery Aneurysms: Insights into Efficacy and Safety from a Systematic Review and Meta-analysis

Changya Liu,Xinxin Wu,Kaikai Guo,Yuting Sun,Cai Yike,Xuebin Hu,Bangjiang Fang

DOI: https://doi.org/10.1007/s12975-024-01251-y

2024-04-12

Translational Stroke Research

Abstract:The objective of this study is to conduct a systematic review and meta-analysis aimed at evaluating the efficacy and safety of flow-diverting devices (FDs) treatment for intracranial vertebral artery (VA) aneurysms. We searched PubMed, Web of Science, OVID, and Embase for English-language studies up to February 2024 and included clinical studies on FD treatment of intracranial VA aneurysms. Sensitivity analysis evaluated outcome stability. Of 2273 articles, 29 studies involving 541 aneurysms treated with FDs were included. Based on the Methodological Index for Non-Randomized Studies (MINORS), six were high-quality and 23 moderate quality. FD treatment showed a 95% rate of favorable clinical outcomes (95% CI, 89–99%), 81% (95% CI, 74–88%) complete aneurysmal occlusion, 4% (95% CI, 2–7%) ischemic complication incidence, 1% (95% CI, 0–3%) hemorrhagic complication incidence, 95% (95% CI, 87–100%) posterior inferior cerebellar artery (PICA) preservation, and 6% (95% CI, 3–10%) in-stent stenosis or occlusion across clinical and angiographic follow-up periods of 13.62 months (95% CI, 10.72–16.52) and 11.85 months (95% CI, 9.36–14.33), respectively. Subgroup analyses, based on a 12-month angiographic follow-up threshold, indicated no statistically significant differences in rates of complete aneurysm occlusion, PICA preservation, or in-stent stenosis or occlusion incidence ( p > 0.05) between subgroups. Moreover, significant differences were observed in clinical and angiographic outcomes between ruptured and unruptured aneurysms, particularly in hemorrhagic complications ( p < 0.05), without significant disparity in ischemic complications ( p > 0.05). The results' stability was confirmed via sensitivity analysis. FDs treatment for VA aneurysms is efficacious and safe, offering high rates of positive clinical and angiographic outcomes with minimal complications, underscoring FDs' viability as a treatment option for VA aneurysms. The study was registered with PROSPERO (registration number: CRD42024499894).

neurosciences,clinical neurology
Flow Diverter Stents for the Treatment of Anterior Cerebral Artery Aneurysms: Safety and Effectiveness

F. Clarençon,F. Di Maria,J. Gabrieli,E. Shotar,C. Zeghal,A. Nouet,J. Chiras,N.-A. Sourour

DOI: https://doi.org/10.1007/s00062-015-0441-8

2015-08-07

Clinical Neuroradiology

Abstract:Background and PurposeFlow diverter stents (FDSs) are increasingly used for the treatment of intracranial aneurysms. Initially developed for the management of giant and large aneurysms, their indications have progressively expanded. The purpose of our study was to evaluate the safety and effectiveness of FDSs for the treatment of anterior cerebral artery (ACA) aneurysms.Materials and MethodsAmong the 94 consecutive patients treated for 100 intracranial aneurysms by means of FDSs in our institution from October 2010 to January 2015, eight aneurysms (8 %) in seven patients were located on the ACA. Three aneurysms were located on the A1 segment, three aneurysms on the anterior communicating artery (ACom) and two on the A2–A3 junction. In three cases, FDS was used for angiographic recurrence after coiling. Five patients were treated with a Pipeline embolization device, one with a NeuroEndograft and the last one with a Silk FDS.ResultsTreatment was feasible in all cases. No technical difficulty was reported. No acute or delayed clinical complication was recorded. Modified Rankin Scale was 0 for six patients and one for one patient. Mean angiographic follow-up was 9.7 ± 3.9 months (range 6–15).Total exclusion was observed in five aneurysms (71.4 %) and neck remnant in two (28.6 %) cases. One patient refused the control DSA.ConclusionOur series shows the safety and effectiveness of FDSs for the treatment of ACA aneurysms.

radiology, nuclear medicine & medical imaging,clinical neurology
Fixation of fractures of the femoral neck.

T. Johansson,G. Neander,C. Rogmark

DOI: https://doi.org/10.1302/0301-620x.86b2.0860308b

Journal of Bone and Joint Surgery - British Volume

Abstract:
Randomized clinical trial of four adhesion strategies in posterior restorations-18-month results.

Flávia B Delbons,J. Perdigão,Edson Araujo,C. A. Melo Freire,D. Caldas,J. L. Cardoso,M. Pagani,G. Borges,Rodrigo B Lima

DOI: https://doi.org/10.1111/jerd.12135

2015-03-01

Journal of Esthetic and Restorative Dentistry

Abstract:PURPOSE To evaluate the 18-month clinical performance of four adhesive strategies in posterior composite restorations placed in private practice. MATERIALS AND METHODS Upon approval by an institutional review board, 144 restorations were inserted in 45 subjects (average age = 32.6) to treat caries lesions or to replace existing restorations in vital molars and premolars. The adhesives OptiBond FL (three-step etch-and-rinse), OptiBond SOLO Plus (two-step etch-and-rinse), OptiBond XTR (two-step self-etch), and OptiBond All-in One (one-step self-etch) were applied as per manufacturer's (Kerr Co.) instructions followed by a nanofilled resin composite (Filtek Z350XT, 3M ESPE) under rubber dam isolation. Restorations were evaluated at baseline and at 18 months using United States Public Health Service (USPHS)-modified criteria and high-resolution digital photographs. Statistical analyses included the McNemar and the Mann-Whitney non-parametric tests (p < 0.05). RESULTS A total of 137 restorations were evaluated after 18 months. The number of alfa ratings did not change significantly from baseline to 18 months for any of the adhesion strategies. When the 18-month evaluation criteria were pooled by pairs of adhesives, none of the adhesives resulted in a significantly different number of alfa ratings for any of the criteria compared with the other adhesives. CONCLUSION Bonding strategy did not influence the clinical performance of posterior composite restorations under the clinical conditions used in this study. CLINICAL SIGNIFICANCE When used in ideal clinical conditions, the composition of current dentin adhesives may be more clinically relevant than their adhesion strategy.
Role of optical coherence tomography in pipeline embolization device for the treatment of vertebral–basilar artery dissecting aneurysms

Yongjie Ma,Zhe Ji,Wanxin Yang,Li Li,Liqiang Han,Yu Liu,Yuanhao Guo,Adam A Dmytriw,Chuan He,Guilin Li,Hongqi Zhang

DOI: https://doi.org/10.1136/jnis-2022-019927

IF: 4.8

2023-03-07

Journal of NeuroInterventional Surgery

Abstract:Background Vertebral–basilar artery dissecting aneurysms (VADAs) are an uncommon phenomenon in all fields of cerebrovascular disease. The flow diverter (FD) can be used as an endoluminal reconstruction device that promotes neointima formation at the aneurysmal neck and preserves the parent artery. To date, imaging examinations such as CT angiography, MR angiography, and DSA are the main methods used to evaluate the vasculature of patients. However, none of these imaging methods can reveal the situation of neointima formation, which is of great importance in evaluating occlusion of VADAs, especially those treated with a FD. Methods Three patients were included in the study from August 2018 to January 2019. All patients underwent preprocedural, postprocedural, and follow-up evaluations with high resolution MRI, DSA, and optical coherence tomography (OCT), as well as the formation of intima on the surface of the scaffold at the 6 month follow-up. Results Preprocedural, postoperative, and follow-up high resolution MRI, DSA, and OCT of all three cases successfully evaluated occlusion of the VADAs and occurrence of in stent stenosis from different views of intravascular angiography and neointima formation. Conclusions OCT was feasible and useful to further evaluate VADAs treated with FD from a near pathological perspective, which may contribute toward guiding the duration of antiplatelet medication and early intervention of in stent stenosis.

surgery,neuroimaging
Optimized gene synthesis, expression and purification of active salivary plasminogen activator alpha2 (DSPAalpha2) of Desmodus rotundus in Pichia pastoris.

Zhao Wei,Yueju Wang,Gangqiang Li,Xiaokun Li,Dehu Liu

IF: 2.025

Protein Expression and Purification

Abstract:Vampire bat salivary plasminogen activators (DSPAs) are thrombolytic agents that are under clinical investigation for the treatment of acute ischemic stroke. In this study, the synthetic active salivary plasminogen activator alpha2 (DSPAalpha2) gene optimized for the preferred codons of Pichia pastoris was assembled from 48 oligonucleotides, and cloned into the yeast expression vector pPIC9 with a strong enhancer from human cytomegalovirus (HCMV). This system achieved high expression of an active DSPAalpha2 in P. pastoris yeast GS115. Secreted active DSPAalpha2 recombinant protein was purified from broth supernatant by a simple one-step procedure on Sephadex chromatography and was confirmed by SDS-PAGE and Western blot analysis. ELISA showed that 2.5mg of recombinant protein could be obtained from 100-ml culture broth supernatant. The fibrinolytic activity of the recombinant DSPAalpha2 was 1.28 x 10(5)IU/mg.
Authors' Reply to "Infliximab in the Treatment of Refractory Ocular Inflammatory Diseases".

K. Kam,A. Young,L. Tam,P. M. K. Tam

DOI: https://doi.org/10.1097/APO.0000000000000124

2015-05-01

Asia-Pacific Journal of Ophthalmology

Abstract:
Endovascular Parent Vessel Occlusion versus Flow diversion in the Treatment of Large and Giant Aneurysms: A randomized comparison

William Boisseau,Tim E Darsaut,Robert Fahed,Pierre Olivier Comby,Brian Drake,Howard Lesiuk,Jeremy L Rempel,Cian J O'Kelly,Michael M C Chow,Daniela Iancu,Daniel Roy,Alain Weill,Ruby Klink,Jean Raymond,Tim E. Darsaut,Jeremy L. Rempel,Cian J. O’Kelly,Michael M.C. Chow

DOI: https://doi.org/10.1016/j.wneu.2024.02.114

IF: 2.21

2024-02-01

World Neurosurgery

Abstract:BACKGROUND AND PURPOSE: Parent vessel occlusion (PVO) is a time-honored treatment for unclippable or uncoilable intracranial aneurysms. Flow diversion (FD) is a recent endovascular alternative that can occlude the aneurysm and spare the parent blood vessel. Our aim was to compare outcomes of FD with endovascular PVO.MATERIALS AND METHODS: This is a pre-specified treatment subgroup analysis of the Flow diversion in Intracranial Aneurysms trial (FIAT). FIAT was an investigator-led parallel-group all-inclusive pragmatic randomized trial. For each patient, clinicians had to pre-specify an alternative management option to FD before stratified randomization. We report all patients for whom PVO was selected as the best alternative treatment to FD. The primary outcome was a composite of core-lab determined angiographic occlusion or near-occlusion at 3-12 months combined with an independent clinical outcome (mRS<3). Primary analyses were intent-to-treat. There was no blinding.RESULTS: There were 45 patients (16.2% of the 278 FIAT patients randomized between 2011 and 2020 in 3 centers): 22 were randomly allocated to FD and 23 to PVO. Aneurysms were mainly large or giant (mean 22mm) anterior circulation (mainly carotid) aneurysms. A poor primary outcome was reached in 11/22 FD (50.0%) compared to 9/23 PVO patients (39.1%) (RR: 1.28, 95%CI [0.66-2.47]; P=.466). Morbidity (mRS >2) at 1 year occurred in 4/22 FD and 6/23 PVO patients. Angiographic results and serious adverse events were similar.CONCLUSIONS: The comparison between PVO and FD was inconclusive. More randomized trials are needed to better determine the role of FD in large aneurysms eligible for PVO.

surgery,clinical neurology
Flow diversion for the treatment of posterior inferior cerebellar artery aneurysms: a novel classification and strategies

Visish M Srinivasan,Michael George Zaki Ghali,Oleg E Reznik,Jacob Cherian,Maxim Mokin,Travis M Dumont,John R Gaughen,Ramesh Grandhi,Ajit S Puri,Stephen R Chen,Jeremiah N Johnson,Peter Kan

DOI: https://doi.org/10.1136/neurintsurg-2017-013427

Abstract:Background: The pipeline embolization device (PED) is frequently used in the treatment of anterior circulation aneurysms, especially around the carotid siphon, with generally excellent results. However, treatment of posterior inferior cerebellar artery (PICA) aneurysms with flow diversion (FD) has not been specifically described or discussed. While there are reports of treating PICA aneurysms using placement of FD stents in the vertebral artery, there are no reports of treating these lesions by placement of flow diverting stents in the PICA vessel itself. Due to the unique anatomy and morphology of these aneurysms, it requires special attention. We assessed our multi-institutional experience treating these lesions, including the first reported cases of the PED placed within the PICA. Methods: Institutional databases of neuroendovascular procedures were reviewed for cases of intracranial aneurysms treated with the PED. Patient and aneurysm data as well as angiographic imaging were reviewed for all cases of PICA aneurysms treated with the PED. PICA aneurysms were defined as aneurysms that involved the PICA. Vertebral aneurysms without disease in the PICA were excluded from the study. Results: 10 PICA aneurysms were treated during the study period. These were classified based on their morphology and location into two main types and five total subtypes for consideration of treatment with flow diversion. All aneurysms were successfully treated, with 8/10 completely obliterated and 2 with a partial reduction in size. Three patients had the PED placed entirely in the PICA and no patient suffered from a medullary or cerebellar stroke. All PEDs were patent and all patients were independent at the last follow-up. Conclusions: The PED may be used successfully to treat select aneurysms of the PICA. We present the first described cases of successful PED treatment of PICA aneurysms with direct placement of the PED in the PICA vessel itself. The proposed classification system aids in that selection.
Standalone Flow Diversion Therapy Effectively Controls Rebleeding of Acutely Ruptured Internal Carotid Artery Trunk (Nonbranching) Microaneurysms

José E Cohen,Hans Henkes,John Moshe Gomori,Gustavo Rajz,Ronen Leker

DOI: https://doi.org/10.3390/jcm10225249

2021-11-11

Abstract:Flow diversion is a promising option in selected patients with acutely ruptured microaneurysms. In this article, we reviewed our experience. Patients with acute spontaneous subarachnoid hemorrhage (SAH) after rupture of a blister-like or saccular microaneurysm (≤2 mm maximal diameter) at a nonbranching ICA site treated from January 2016 to June 2019 using flow diversion as standalone therapy were included in this study. An EVD was usually placed preventively. Antiplatelet effects of pre-procedure DAPT were evaluated (target PRU, 80-160). After the intervention, DAPT was continued for ≥6 months, aspirin-indefinitely. Angiographic controls were obtained. Fifteen patients (12 female; mean age, 46.4 years) with 15 ruptured ICA microaneurysms (mean diameter, 1.8 mm) were included. An EVD was placed in 12 patients (75%) before DAPT administration and stenting. PRU values immediately before FDS were 1-134 (mean, 72.1). One patient died 27 days after flow diversion due to a suspected fulminant pulmonary embolism. Aneurysms were completely occluded at the 6-12-month angiographic follow-up in 14/14 surviving patients, with no rebleeding at a mean of 14 months. Late mRS was 0-2 in 13/14 patients and 3 in one due to sequelae of the original hemorrhage. Flow diversion provided robust aneurysm rebleeding control. Angiographic follow-up confirmed complete aneurysm occlusion in all the cases.
Utilizing the Trans-Cell Approach as a Salvage Treatment for an Unopened Flow Redirection Endoluminal Device in a Flow-Related Aneurysm Associated with Arteriovenous Malformation: A Case Report

Ho-Hsian Yen,Yen-Jun Lai

DOI: https://doi.org/10.5812/ijradiol-139475

2024-06-19

Iranian Journal of Radiology

Abstract:Introduction: We report the first case demonstrating the viability of the trans-cell approach as a salvage strategy in situations where Flow Redirection Endoluminal Devices (FREDs) fail to open. Case Presentation: A 64-year-old woman was admitted to our facility after a motorcycle accident. During her examination, an arteriovenous malformation (AVM) in the right temporal lobe was incidentally discovered. The AVM was associated with large flow-related aneurysms in the bilateral supraclinoid internal carotid artery (ICA), as revealed by computed tomography and magnetic resonance imaging. The AVM was surgically removed, and the aneurysm was treated endovascularly using a FRED. However, the middle section of the FRED failed to open post-deployment. We successfully carried out a salvage therapy using the stent strut technique with a Headway Duo microcatheter for coiling. Conclusion: The trans-cell technique utilizing a Headway Duo 156 microcatheter can be an effective salvage treatment for unopened FRED stents used in brain aneurysm cases.

radiology, nuclear medicine & medical imaging
Anatomical Flow Diversion by Hybrid Strategy for Intractable Large Cerebral Aneurysms

Wataro Tsuruta,Takayuki Hara,Satoshi Miyamoto,Jun Isozaki,Daiichiro Ishigami,Hisayuki Hosoo,Yoshiro Ito,Mikito Hayakawa,Aiki Marushima,Yuji Matsumaru

DOI: https://doi.org/10.1007/s00062-024-01452-w

2024-08-27

Abstract:Background and importance: Flow diverters (FDs) provide curative endovascular treatment for wide-necked sidewall aneurysms. The efficacy of FDs for bifurcation or branching sidewall aneurysms is probably limited. We used anatomical flow diversion (AFD) for intractable large cerebral aneurysms. We report our experiences with AFD. Methods: The concept of AFD is the transformation from the bifurcation or branching sidewall type to the nonbranching sidewall type. Linearization of the parent artery by stenting, intentional branch occlusion, and aneurysmal coil embolization were performed. Furthermore, bypass surgery is performed for patients intolerant to branch occlusions. We evaluated the clinical outcomes of intractable aneurysms treated with AFD. Results: AFD was performed in seven unruptured large aneurysms. Aneurysmal locations were the top of the basilar artery (BA), BA-superior cerebellar artery (SCA), internal carotid artery (IC)-posterior communicating artery (PcomA), and IC terminal. The mean dome diameter was 17.0 ± 4.6 mm. Six patients underwent bypass surgery. The occluded branches were the PCA + SCA, PcomA, and anterior cerebral artery (ACA) A1. An FD was used in three patients and a neck bridge stent in four patients. No intraprocedural complications occurred. Two postprocedural ischemic complications occurred in one patient. Six (86%) patients demonstrated a modified Rankin Scale (mRS) 0 at the 3-month follow-up, and one with an ischemic complication showed an mRS 5. Complete occlusion of all aneurysms was maintained with a median follow-up duration of 60 months. Conclusion: AFD is useful for intractable large cerebral aneurysms with high curability, although safety verification is required.
Screening -- the Trojan horse in preventive medicine?

A. Jahn

Tropical Medicine & International Health

Abstract:
Treatment of medullary aneurysm in the collateral circulation with a flow diverter: A case report

Yuhao Zhao,Jinlu Yu

DOI: https://doi.org/10.1016/j.ijscr.2024.110038

Abstract:Introduction and importance: Spinal aneurysms rarely occur in the collateral circulation of the vertebral artery (VA). These aneurysms are difficult to treat. A flow diverter (FD) can be a therapeutic option. Case presentation: A 62-year-old man suffered subarachnoid hemorrhage. His Hunt-Hess scale classification was grade II. Digital subtraction angiography (DSA) revealed that the bilateral distal VAs were occluded, there were two flow-related aneurysms in the collateral circulation of the first radicular artery of the VA, and there was a dissecting aneurysm at the origin of the posterior inferior cerebellar artery (PICA). The FD covered the PICA dissecting aneurysm, and the first radicular artery originated in the VA. Postoperatively, computed tomography angiography revealed a patent PICA and regression of the aneurysm in the collateral circulation. At the one-month follow-up, he showed good recovery and was therefore allowed to return to work. Follow-up DSA confirmed the regression of the aneurysms. However, the intracranial VA and PICA were unexpectedly occluded. Clinical discussion: It is difficult to catheterize aneurysms in the collateral circulation to perform coiling. It is also dangerous to embolize such aneurysms with a liquid embolic agent. After FD deployment to cover the origin of the parent artery, the hemodynamic stress of the aneurysm decreases, and the aneurysm can regress. Conclusion: Aneurysms in the collateral circulation were not accessible. FD deployment in the parent artery to cover the origin of the feeding artery of the collateral circulation is feasible for treating such aneurysms.
Jian-Kang Liu: A pioneer of sex determination studies in vertebrates

Li Zhou,J. Gui

DOI: https://doi.org/10.1007/s13238-015-0232-7

2015-12-19

Protein & Cell

Abstract:
Review of current intracranial aneurysm flow diversion technology and clinical use

Sudeepta Dandapat,Alan Mendez-Ruiz,Mario Martínez-Galdámez,Juan Macho,Shahram Derakhshani,Gustavo Foa Torres,Vitor M Pereira,Anil Arat,Ajay K Wakhloo,Santiago Ortega-Gutierrez

DOI: https://doi.org/10.1136/neurintsurg-2020-015877

Abstract:Endovascular treatment of intracranial aneurysms (IAs) has evolved considerably over the past decades. The technological advances have been driven by the experience that coils fail to completely exclude all IAs from the blood circulation, the need to treat the diseased parent vessel segment leading to the aneurysm formation, and expansion of endovascular therapy to treat more complex IAs. Stents were initially developed to support the placement of coils inside wide neck aneurysms. However, early work on stent-like tubular braided structure led to a more sophisticated construct that then later was coined as a flow diverter (FD) and found its way into clinical application. Although FDs were initially used to treat wide-neck large and giant internal carotid artery aneurysms only amenable to surgical trap with or without a bypass or endovascular vessel sacrifice, its use in other types of IAs and cerebrovascular pathology promptly followed. Lately, we have witnessed an explosion in the application of FDs and subsequently their modifications leading to their ubiquitous use in endovascular therapy. In this review we aim to compile the available FD technology, evaluate the devices' peculiarities from the authors' perspective, and analyze the current literature to support initial and expanded indications, recognizing that this may be outdated soon.

Regulatory T cells are present in Kaposi's sarcoma and increasingly frequent in advanced disease

Treatment of visceral artery aneurysms and pseudoaneurysms with the use of cerebral flow diverting stents: initial experience

Flow Diverter in Unruptured Intracranial Vertebral Artery Dissecting Aneurysm

Endovascular treatment of distal anterior cerebral artery aneurysms using flow modulation devices: mid- and long-term results from a two-center study

Flow diverters in the treatment of unruptured vertebral artery dissecting aneurysm: A single-center experience.

Flow-Diverting Devices in the Treatment of Vertebral Artery Aneurysms: Insights into Efficacy and Safety from a Systematic Review and Meta-analysis

Flow Diverter Stents for the Treatment of Anterior Cerebral Artery Aneurysms: Safety and Effectiveness

Fixation of fractures of the femoral neck.

Randomized clinical trial of four adhesion strategies in posterior restorations-18-month results.

Role of optical coherence tomography in pipeline embolization device for the treatment of vertebral–basilar artery dissecting aneurysms

Optimized gene synthesis, expression and purification of active salivary plasminogen activator alpha2 (DSPAalpha2) of Desmodus rotundus in Pichia pastoris.

Authors' Reply to "Infliximab in the Treatment of Refractory Ocular Inflammatory Diseases".

Endovascular Parent Vessel Occlusion versus Flow diversion in the Treatment of Large and Giant Aneurysms: A randomized comparison

Flow diversion for the treatment of posterior inferior cerebellar artery aneurysms: a novel classification and strategies

Standalone Flow Diversion Therapy Effectively Controls Rebleeding of Acutely Ruptured Internal Carotid Artery Trunk (Nonbranching) Microaneurysms

Utilizing the Trans-Cell Approach as a Salvage Treatment for an Unopened Flow Redirection Endoluminal Device in a Flow-Related Aneurysm Associated with Arteriovenous Malformation: A Case Report

Anatomical Flow Diversion by Hybrid Strategy for Intractable Large Cerebral Aneurysms

Screening -- the Trojan horse in preventive medicine?

Treatment of medullary aneurysm in the collateral circulation with a flow diverter: A case report

Jian-Kang Liu: A pioneer of sex determination studies in vertebrates

Review of current intracranial aneurysm flow diversion technology and clinical use